{"entity":{"type":"insider","cik":"0001623567","url":"/insider/0001623567","json_url":"/insider/0001623567.json","name":"Happel David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2023-11-20","last":"2026-07-22","span_basis":"filed_date"},"name_variants":[{"name":"Happel David","source":"filing","n_filings":6,"first_seen":"2023-11-20","last_seen":"2026-07-22"}],"transactions":[{"id":5785682,"accession":"0001193125-26-312397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-312397","line_url":"/filing/0001193125-26-312397#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001623567","owner_name":"Happel David","owner_display_name":"Happel David","owner_url":"/insider/0001623567","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64051.0,"shares_display":"64,051","price_per_share":7.7605,"price_display":"7.76","price_state":"stated","total_value":497067.7855,"total_display":"497,067.79","total_whole":"497,068","shares_owned_after":741570.0,"shares_owned_after_display":"741,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-20","filed_date":"2026-07-22","scope":"insider"},{"id":5833303,"accession":"0001104659-26-014283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-014283","line_url":"/filing/0001104659-26-014283#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001623567","owner_name":"Happel David","owner_display_name":"Happel David","owner_url":"/insider/0001623567","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12101.0,"shares_display":"12,101","price_per_share":5.3603,"price_display":"5.36","price_state":"stated","total_value":64864.9903,"total_display":"64,864.99","total_whole":"64,865","shares_owned_after":677621.0,"shares_owned_after_display":"677,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-12","scope":"insider"},{"id":4986766,"accession":"0001104659-25-070017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-070017","line_url":"/filing/0001104659-25-070017#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001623567","owner_name":"Happel David","owner_display_name":"Happel David","owner_url":"/insider/0001623567","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65478.0,"shares_display":"65,478","price_per_share":9.1346,"price_display":"9.13","price_state":"stated","total_value":598115.3388,"total_display":"598,115.34","total_whole":"598,115","shares_owned_after":689722.0,"shares_owned_after_display":"689,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-21","filed_date":"2025-07-23","scope":"insider"},{"id":2471486,"accession":"0001104659-24-040517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-040517","line_url":"/filing/0001104659-24-040517#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001623567","owner_name":"Happel David","owner_display_name":"Happel David","owner_url":"/insider/0001623567","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Series A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12100.0,"shares_display":"12,100","price_per_share":5.267,"price_display":"5.27","price_state":"stated","total_value":63730.7,"total_display":"63,730.70","total_whole":"63,731","shares_owned_after":639200.0,"shares_owned_after_display":"639,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-26","filed_date":"2024-03-28","scope":"insider"},{"id":8357736,"accession":"0001104659-23-124678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-124678","line_url":"/filing/0001104659-23-124678#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001623567","owner_name":"Happel David","owner_display_name":"Happel David","owner_url":"/insider/0001623567","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Series A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":6560.0,"total_display":"6,560.00","total_whole":"6,560","shares_owned_after":627100.0,"shares_owned_after_display":"627,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-08","scope":"insider"},{"id":7804294,"accession":"0001104659-23-120027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-120027","line_url":"/filing/0001104659-23-120027#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001623567","owner_name":"Happel David","owner_display_name":"Happel David","owner_url":"/insider/0001623567","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Series A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":590.0,"shares_display":"590","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":1386.5,"total_display":"1,386.50","total_whole":"1,387","shares_owned_after":590.0,"shares_owned_after_display":"590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001400118","name":"Sagimet Biosciences Inc.","url":"/issuer/0001400118","role":"Director, Officer (President & CEO)","n_filings":6,"first_seen":"2023-11-20","last_seen":"2026-07-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001623567","retrieved_at":"2026-08-24T13:11:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}